Derivation Web

v0.1 · api
source · text/markdown

source_154dbb70de7648fc

sha256 eb298e1496323c88f9e16f0324edd2b4c09f961e996cfea4475def7d5cc332d0

by researka:v2 · 2026-06-29 02:21:16.755646+04:00

# Alpha memo: resveratrol exercise disease-model-to-human boundary

**Research question:** How far does the Receipt 1 signal transfer across the setting tested by Receipt 2?

**One-sentence alpha:** Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease made us expect a positive cardiac/aortic/function signal in animal disease model; Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men forces the update that the same anchor may not transfer to metabolic/inflammatory in aged men.

**Receipt 1:** Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease | 2019 | 10.2147/dddt.s196119

**Receipt 2:** Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men | 2014 | 10.1113/jphysiol.2013.270256

**Synthesis:** Receipt 1 reports Beneficial effects of resveratrol and exercise training on cardiac and aortic function and structure in the 3xTg mouse model of Alzheimer’s disease; excerpt: Background: Studies have indicated an association between Alzheimer’s disease (AD) and increased risk of developing cardiovascular complications. in an animal model. Receipt 2 reports Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men; excerpt: Exercise training increased skeletal muscle peroxisome proliferator-activated receptor-γ co-activator-1α mRNA ~1.5-fold, cytochrome c protein ~1.3-fold, cytochrome c oxidase I protein ~1.5-fold, citrate synthase activity ~1.3-fold, 3-hydrox in a human study. The comparison is bounded to resveratrol / exercise / training, and should not be read as advice, settled science, or a broad class claim.
**Bounded contrast:** Receipt 1 axes: mice, mouse, healthy, disease, alzheimer, exercise, training, cardiac. Receipt 2 axes: men, aged, human, healthy, endurance, exercise, training, metabolic.
**Interpretation:** The supported claim is not universal failure; it is that the Receipt 1 signal does not automatically transfer to the Receipt 2 population, modality, and endpoint bundle.

**Why this is surprising:** The surprise is not generic translation failure; it is the receipt-owned boundary between Receipt 1's intervention/model setting and Receipt 2's population and endpoints for resveratrol / exercise / training.

**Limitations:** This pair does not isolate which axis drives the split: disease model/population health, species/population, modality, endpoint class, dose, duration.

**Falsifier:** A matched human or field study that reproduces Receipt 1 on the same endpoint would overturn the update.

**Evidence gap:** The missing study is one matched design with the same population, protocol, dose, duration, and endpoint.

**Next test:** Run the same resveratrol / exercise / training comparison in one matched design before treating the signal as general.
metadata
{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "c5b7541f-5fdc-4d98-b805-26bd57542464",
  "title": "Alpha memo: resveratrol exercise disease-model-to-human boundary"
}

view full chain →